A detailed history of Brevan Howard Capital Management LP transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 29,488 shares of HCAT stock, worth $111,464. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,488
Previous 13,065 125.7%
Holding current value
$111,464
Previous $92,000 44.57%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$3.97 - $7.42 $65,199 - $121,858
16,423 Added 125.7%
29,488 $133,000
Q4 2024

Feb 14, 2025

BUY
$6.9 - $9.02 $90,148 - $117,846
13,065 New
13,065 $92,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $207M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.